Data / Form D filings / Cambium Biomaterials, Inc.
Cambium Biomaterials, Inc.: Form D filings
Cambium Biomaterials, Inc., a technology company in El Segundo, CA, filed 3 Form D notices with the SEC between 2021 and 2025. The latest, on December 4, 2025, reports $94.4 million sold of a $101.4 million offering to 33 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 111 Maryland Street, El Segundo, CA, 90245
- Phone
- (415) 878-3752
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1883516
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | New notice | $101,399,993 | $94,366,494 | $7,033,499 | 33 | Nov 18, 2025 | sec.gov |
| Nov 14, 2023 | New notice | $19,978,890 | $17,364,116 | $2,614,774 | 16 | Nov 8, 2023 | sec.gov |
| Sep 17, 2021 | New notice | $28,014,379 | $8,012,877 | $20,001,502 | 3 | Sep 2, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Pederson | Director | |
| Brett Schneider | Director | |
| Francisco Gimenez | Director | |
| Tim Gardner | Executive Officer | |
| Stephan Herrera | Executive Officer | |
| Simon Waddington | Executive Officer, Director | |
| James Griffin | Executive Officer | |
| Nic Madren | Executive Officer |
Other technology companies in California that filed recently
- Redwagon Systems Inc. $1.2 million · Oct 30, 2026
- General Compute Inc. $132.2 million · Oct 30, 2026
- Promptiva Health Inc. offering · Oct 30, 2026
- thenevercompany.ai Inc. $200,000 · Oct 29, 2026
- TrashLab Software Inc. $10.7 million · Oct 29, 2026
- Vasopore, Inc. $1.1 million · Oct 28, 2026
Every Form D from the week of Dec 1, 2025 · All recent filings in California · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Cambium Biomaterials, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.